Moreover, several antineoplastic therapies such as anthracyclines and HER2-targeted therapies (used more commonly in females to treat breast cancer), and radiation therapy are potentially cardiotoxic, adding to the likelihood of developing HF. Here, ERBB2 is linked to breast carcinoma.